GSK, Sanofi COVID-19 vaccine delayed until late 2021 - Business Insider
Companies, agencies, institutions, etc
GlaxoSmithKline
Sanofi
the US Biomedical Advanced Research and Development Authority (BARDA
Operation Warp Speed
vaccine.""No
EU
World Health Organization
Pfizer-BioNTech
Food and Drug Administration
FDA
Business Insider Intelligence
People
Thomas Triomphe
Covax
Groups
COVID-19
Americans
vaccine's
French
Pfizer's
Physical locations
West
Places
No matching tags
Locations
vaccine's
Sanofi's
UK
US
Canada
Events
No matching tags
Summary
Depending on the results, the companies hope to submit the vaccine for authorization in the second half of 2021, which could make roll-out possible in the final quarter of the year.Initially the companies had expected the vaccine to be available from mid-2021.The companies are "disappointed" by the delay, Thomas Triomphe, executive vice president of French drugmaker Sanofi, said, but noted they "remain confident and committed to bringing a safe and efficacious COVID-19 vaccine.""No single pharma company can make it alone; the world needs more than one vaccine to fight the pandemic," he added.Millions of doses of GlaxoSmithKline and Sanofi's vaccine have been pre-ordered as countries scramble for the shots amid climbing COVID-19 cases across the world.
As said here by Grace Dean